Skip to content

A Randomized Controlled Clinical Trial Using Portable EEG Devices to Evaluate the Effect of Essential Oil Ointments on Improving Insomnia in Healthcare Workers

A Randomized Controlled Clinical Trial Using Portable EEG Devices to Evaluate the Effect of Essential Oil Ointments on Improving Insomnia in Healthcare Workers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129583
Enrollment
Unknown
Registered
2026-08-06
Start date
2026-08-15
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Intervention group:Received standard sleep hygiene education and selected standardized plant essential oil balm. Through the bedroom diffuser method, start using it 30 minutes before going to bed, onc
Control group:Receive standard sleep hygiene education, use ordinary balm with the same scent and packaging, and start using it 30 minutes before going to bed through bedroom diffusion. Do it once a d

Sponsors

The First Hospital Of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. According to the 3rd edition of the Chinese Diagnostic Classification of Mental Disorders, insomnia was diagnosed; 2. Age range: 18 to 60 years old; 3. Self-assessment score of the Sleep Rating Scale (SRSS) > 23 points; 4. Normal cognitive function; 5. No use of any drugs related to sleep; 6. No neurological diseases that affect the collection of brain signals (such as epilepsy, history of brain trauma or neurodegenerative diseases), to ensure the accuracy and safety of the brain-computer interface equipment; 7. Complete scalp, without skin lesions or wounds, facilitating the placement of electrodes and signal transmission of portable electroencephalography equipment; 8. Able to understand and independently or under guidance correctly wear and use portable electroencephalography equipment, which is a basic requirement for brain-computer interface monitoring.

Exclusion criteria

Exclusion criteria: 1. Individuals with olfactory disorders or loss of smell; 2. Patients with other sleep disorders such as sleep apnea-hypopnea syndrome, restless legs syndrome, etc. 3. Those with allergies to pollen or drugs; 4. Patients with serious physical or mental disorders that are directly related to insomnia; 5. Pregnant and lactating women; 6. Individuals with a history of neurological diseases, including epilepsy, family history of epilepsy, migraines, brain trauma or unexplained loss of consciousness, to avoid interference of brain-computer interface device signals or safety risks; 7. Those with implanted cardiac pacemakers, intracranial metal implants or other electronic implants that may affect brain electrical signals; 8. Those who cannot understand the research protocol or cannot provide informed consent; 9. Those with known allergies to electrode materials, adhesives or related accessories to ensure the safe use of brain-computer interface devices; 10. Those with current or past mental illness history, which may affect the interpretation of brain-computer interface data or trial compliance.

Design outcomes

Primary

MeasureTime frame
Sleep latency;(Percentage of (S3 + S4) / Proportion of deep sleep);Actual sleep time;

Secondary

MeasureTime frame
Insomnia Severity Index (ISI);Pittsburgh Sleep Quality Index (PSQI);

Countries

China

Contacts

Public ContactHu Jin

The First Hospital Of Jiaxing

184381954@qq.com+86 573 82519899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026